Zkusit zdarma
Icosavax, Inc.

Icosavax, Inc.

ICVX
Cena:
 
 
Valuace
70
Růst
45
Zdraví
100
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Icosavax, Inc. (ICVX) Is Up 0.10% in One Week: What You Should Know

Icosavax, Inc. (ICVX) Is Up 0.10% in One Week: What You Should Know

13:32 13-12-2023

Does Icosavax, Inc. (ICVX) have what it takes to be a top stock pick for momentum investors? Let's f...

Icosavax, Inc. (ICVX) Moves to Buy: Rationale Behind the Upgrade

Icosavax, Inc. (ICVX) Moves to Buy: Rationale Behind the Upgrade

13:32 13-12-2023

Icosavax, Inc. (ICVX) might move higher on growing optimism about its earnings prospects, which is r...

Why Is Icosavax (ICVX) Stock Up 46% Today?

Why Is Icosavax (ICVX) Stock Up 46% Today?

8:07 12-12-2023

Icosavax (NASDAQ: ICVX ) stock is rising higher on Tuesday after announcing a major acquisition dea...

Wall Street Analysts Believe Icosavax, Inc. (ICVX) Could Rally 175.87%: Here's is How to Trade

Wall Street Analysts Believe Icosavax, Inc. (ICVX) Could Rally 175.87%: Here's is How to Trade

11:16 08-12-2023

The average of price targets set by Wall Street analysts indicates a potential upside of 175.9% in I...

Icosavax, Inc. (ICVX) is on the Move, Here's Why the Trend Could be Sustainable

Icosavax, Inc. (ICVX) is on the Move, Here's Why the Trend Could be Sustainable

10:34 04-12-2023

Icosavax, Inc. (ICVX) could be a solid choice for shorter-term investors looking to capitalize on th...

close

ICOSAVAX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF ICOSAVAX, INC. - ICVX

26-01-2024
NEW ORLEANS , JAN. 26, 2024 /PRNEWSWIRE/ -- FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, J...
Více zde

ICVX STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF ICOSAVAX, INC. IS FAIR TO SHAREHOLDERS

03-01-2024
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER T...
Více zde

ICOSAVAX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF ICOSAVAX, INC. - ICVX

29-12-2023
NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ESQ. AND TH...
Více zde

ICOSAVAX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF ICOSAVAX, INC. - ICVX

14-12-2023
NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ESQ. AND TH...
Více zde

SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER ICOSAVAX, INC. HAS OBTAINED A FAIR PRICE IN ITS TRANSACTION WITH ASTRAZENECA

12-12-2023
MILWAUKEE , DEC. 12, 2023 /PRNEWSWIRE/ -- ADEMI LLP IS INVESTIGATING ICOSAVAX (NASDAQ: ICVX) FOR POS...
Více zde

ICVX STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF ICOSAVAX, INC. IS FAIR TO SHAREHOLDERS

12-12-2023
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER T...
Více zde

ASTRAZENECA TO ACQUIRE ICOSAVAX, INCLUDING POTENTIAL FIRST-IN-CLASS RSV AND HMPV COMBINATION VACCINE WITH POSITIVE PHASE II DATA

12-12-2023
WILMINGTON, DEL.--(BUSINESS WIRE)--ASTRAZENECA HAS ENTERED INTO A DEFINITIVE AGREEMENT TO ACQUIRE IC...
Více zde

ICOSAVAX, INC. ANNOUNCES AGREEMENT TO BE ACQUIRED BY ASTRAZENECA

12-12-2023
- ICOSAVAX STOCKHOLDERS TO RECEIVE $15.00 PER SHARE IN CASH AT CLOSING PLUS NON-TRADEABLE CONTINGENT...
Více zde

ICOSAVAX ANNOUNCES POSITIVE TOPLINE INTERIM PHASE 2 RESULTS FOR COMBINATION VLP VACCINE CANDIDATE IVX-A12 AGAINST RSV AND HMPV IN OLDER ADULTS

12-12-2023
– IVX-A12 INDUCED ROBUST IMMUNE RESPONSES AT DAY 28 TO BOTH RSV AND HMPV, AND WAS GENERALLY WELL T...
Více zde

ICOSAVAX REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

14-11-2023
- REPORTED POSITIVE TWELVE-MONTH DURABILITY DATA AND INITIAL PROOF-OF-CONCEPT FOR REVACCINATION WITH...
Více zde

ICOSAVAX TO PARTICIPATE IN THE JEFFERIES LONDON HEALTHCARE CONFERENCE

08-11-2023
SEATTLE, NOV. 08, 2023 (GLOBE NEWSWIRE) -- ICOSAVAX, INC. (NASDAQ: ICVX), A BIOPHARMACEUTICAL COMPAN...
Více zde

ICOSAVAX TO PARTICIPATE IN THE GUGGENHEIM HEALTHCARE TALKS 5TH ANNUAL INFLAMMATION, NEUROLOGY & IMMUNOLOGY (INI) CONFERENCE

31-10-2023
SEATTLE, OCT. 31, 2023 (GLOBE NEWSWIRE) -- ICOSAVAX, INC. (NASDAQ: ICVX), A BIOPHARMACEUTICAL COMPAN...
Více zde

ICOSAVAX TO PARTICIPATE IN THE CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCE 2023

19-09-2023
SEATTLE, SEPT. 19, 2023 (GLOBE NEWSWIRE) -- ICOSAVAX, INC. (NASDAQ: ICVX), A BIOPHARMACEUTICAL COMPA...
Více zde

ICOSAVAX REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

14-08-2023
- POSITIVE TOPLINE INTERIM PHASE 1 RESULTS FOR BIVALENT VLP VACCINE CANDIDATE IVX-A12 AGAINST RSV AN...
Více zde

ICOSAVAX REPORTS POSITIVE 12-MONTH DURABILITY DATA FOR VLP VACCINE CANDIDATE IVX-121 AGAINST RSV AND INITIAL EVIDENCE FOR REVACCINATION POTENTIAL

08-08-2023
- IN NEW DATA FROM ICOSAVAX'S IVX-121 PHASE 1B EXTENSION TRIAL IN OLDER ADULTS, GMTS AGAINST RSV THR...
Více zde

ICOSAVAX INITIATES PHASE 2 TRIAL OF IVX-A12 AGAINST RSV AND HMPV IN OLDER ADULTS

20-06-2023
- PHASE 2 TOPLINE INTERIM RESULTS EXPECTED IN 1Q 2024 - - 6-MONTH DURABILITY DATA FOR PHASE 1 TRIAL...
Více zde

ICOSAVAX ANNOUNCES $67.8 MILLION REGISTERED DIRECT OFFERING OF COMMON STOCK

22-05-2023
SEATTLE, MAY 22, 2023 (GLOBE NEWSWIRE) -- ICOSAVAX, INC. (NASDAQ: ICVX), A BIOPHARMACEUTICAL COMPANY...
Více zde

ICOSAVAX ANNOUNCES POSITIVE TOPLINE INTERIM PHASE 1 RESULTS FOR BIVALENT VLP VACCINE CANDIDATE IVX-A12 AGAINST RSV AND HMPV IN OLDER ADULTS

22-05-2023
–  IVX-A12 INDUCED ROBUST IMMUNE RESPONSES AT DAY 28 TO BOTH RSV AND HMPV IN OLDER ADULTS – ...
Více zde

ICOSAVAX REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

30-03-2023
- FDA GRANTED FAST TRACK DESIGNATION FOR IVX-A12, A BIVALENT RESPIRATORY SYNCYTIAL VIRUS (RSV) AND H...
Více zde

ICOSAVAX TO PARTICIPATE IN THE UPCOMING HEALTHCARE CONFERENCES

28-02-2023
SEATTLE, FEB. 28, 2023 (GLOBE NEWSWIRE) -- ICOSAVAX, INC. (NASDAQ: ICVX), A BIOPHARMACEUTICAL COMPAN...
Více zde

ICOSAVAX GRANTED FDA FAST TRACK DESIGNATION FOR IVX-A12

21-02-2023
SEATTLE, FEB. 21, 2023 (GLOBE NEWSWIRE) -- ICOSAVAX, INC. (NASDAQ: ICVX), A BIOPHARMACEUTICAL COMPAN...
Více zde

ICOSAVAX PROVIDES CORPORATE UPDATE AND ANTICIPATED MILESTONES FOR 2023

06-01-2023
- RECENTLY REPORTED POSITIVE SIX-MONTH IMMUNOGENICITY DATA FOR IVX-121 AGAINST RSV; FIRST CLINICAL E...
Více zde

ICOSAVAX REPORTS POSITIVE DURABILITY DATA FOR VLP VACCINE CANDIDATE IVX-121 AGAINST RSV AT SIX-MONTH TIMEPOINT

13-12-2022
- IN NEW DATA FROM PHASE 1/1B STUDY, IVX-121 SHOWED SUSTAINED IMMUNOLOGIC RESPONSE AT SIX MONTHS; GE...
Více zde

ICOSAVAX TO PARTICIPATE IN THE EVERCORE ISI HEALTHCONX CONFERENCE

22-11-2022
SEATTLE, NOV. 22, 2022 (GLOBE NEWSWIRE) -- ICOSAVAX, INC. (NASDAQ: ICVX), A BIOPHARMACEUTICAL COMPAN...
Více zde

ICOSAVAX TO PARTICIPATE IN IN UPCOMING INVESTOR CONFERENCES

08-11-2022
SEATTLE, NOV. 08, 2022 (GLOBE NEWSWIRE) -- ICOSAVAX, INC. (NASDAQ: ICVX), A BIOPHARMACEUTICAL COMPAN...
Více zde

ICOSAVAX INITIATES PHASE 1 TRIAL OF IVX-A12 AGAINST RSV AND HMPV IN OLDER ADULTS

04-10-2022
- IVX-A12 IS THE FIRST COMBINATION BIVALENT VACCINE CANDIDATE AGAINST BOTH RESPIRATORY SYNCYTIAL VIR...
Více zde

ICOSAVAX ANNOUNCES RESULTS FROM IVX-411 DRUG PRODUCT INVESTIGATION AND OUTLINES ADDITIONAL CORPORATE MILESTONES

28-07-2022
- ANTIGEN COMPONENT OF IVX-411 FOUND TO BE UNSTABLE; ISSUE SPECIFIC TO MOLECULE, WITH NO EVIDENCE OF...
Více zde

ICOSAVAX TO PARTICIPATE IN THE WILLIAM BLAIR BIOTECH FOCUS CONFERENCE

06-07-2022
SEATTLE, JULY 06, 2022 (GLOBE NEWSWIRE) -- ICOSAVAX, INC. (NASDAQ: ICVX), A BIOPHARMACEUTICAL COMPAN...
Více zde

ICOSAVAX ANNOUNCES POSITIVE TOPLINE INTERIM PHASE 1/1B RESULTS FOR VLP VACCINE CANDIDATE IVX-121 AGAINST RSV

28-06-2022
- IVX-121 DEMONSTRATED ROBUST IMMUNOLOGIC RESPONSE TO RSV, WITH COMPARABLE GEOMETRIC MEAN TITER (GMT...
Více zde

ICOSAVAX TO PARTICIPATE IN THE JEFFERIES HEALTHCARE CONFERENCE

01-06-2022
SEATTLE, JUNE 01, 2022 (GLOBE NEWSWIRE) -- ICOSAVAX, INC. (NASDAQ: ICVX), A BIOPHARMACEUTICAL COMPAN...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2024-02-20 00:00:008-KStáhnout
2024-02-19 23:00:008-KStáhnout
2023-12-12 00:00:008-KStáhnout
2023-12-11 23:00:008-KStáhnout
2023-11-14 00:00:008-KStáhnout
2023-11-14 00:00:0010-QStáhnout
2023-11-13 23:00:008-KStáhnout
2023-11-13 23:00:0010-QStáhnout
2023-08-14 01:00:008-KStáhnout
2023-08-14 01:00:0010-QStáhnout
2023-08-14 00:00:008-KStáhnout
2023-08-14 00:00:0010-QStáhnout
2023-08-08 01:00:008-KStáhnout
2023-08-08 00:00:008-KStáhnout
2023-06-09 01:00:008-KStáhnout
2023-06-09 00:00:008-KStáhnout
2023-05-23 01:00:008-KStáhnout
2023-05-23 00:00:008-KStáhnout
2023-05-22 01:00:008-KStáhnout
2023-05-22 00:00:008-KStáhnout
2023-05-10 01:00:008-KStáhnout
2023-05-10 01:00:0010-QStáhnout
2023-05-10 00:00:008-KStáhnout
2023-05-10 00:00:0010-QStáhnout
2023-03-30 01:00:008-KStáhnout
2023-03-30 01:00:0010-KStáhnout
2023-03-30 00:00:008-KStáhnout
2023-03-30 00:00:0010-KStáhnout
2022-12-13 00:00:008-KStáhnout
2022-12-12 23:00:008-KStáhnout
2022-11-14 00:00:008-KStáhnout
2022-11-14 00:00:0010-QStáhnout
2022-11-13 23:00:008-KStáhnout
2022-11-13 23:00:0010-QStáhnout
2022-08-15 01:00:008-KStáhnout
2022-08-15 01:00:0010-QStáhnout
2022-08-15 00:00:008-KStáhnout
2022-08-15 00:00:0010-QStáhnout
2022-06-28 01:00:008-KStáhnout
2022-06-28 00:00:008-KStáhnout
2022-06-15 01:00:008-KStáhnout
2022-06-15 00:00:008-KStáhnout
2022-05-16 01:00:008-KStáhnout
2022-05-16 01:00:0010-QStáhnout
2022-05-16 00:00:008-KStáhnout
2022-05-16 00:00:0010-QStáhnout
2022-04-25 01:00:008-KStáhnout
2022-04-25 00:00:008-KStáhnout
2022-03-30 01:00:008-KStáhnout
2022-03-30 01:00:0010-KStáhnout
2022-03-30 00:00:008-KStáhnout
2022-03-30 00:00:0010-KStáhnout
2022-03-25 00:00:008-KStáhnout
2022-03-24 23:00:008-KStáhnout
2022-02-11 00:00:008-KStáhnout
2022-02-10 23:00:008-KStáhnout
2022-01-07 00:00:008-KStáhnout
2022-01-06 23:00:008-KStáhnout
2022-01-05 00:00:008-KStáhnout
2022-01-04 23:00:008-KStáhnout
2021-12-16 00:00:008-KStáhnout
2021-12-15 23:00:008-KStáhnout
2021-11-18 00:00:008-KStáhnout
2021-11-17 23:00:008-KStáhnout
2021-11-15 00:00:008-KStáhnout
2021-11-15 00:00:0010-QStáhnout
2021-11-14 23:00:008-KStáhnout
2021-11-14 23:00:0010-QStáhnout
2021-09-13 01:00:008-KStáhnout
2021-09-13 01:00:0010-QStáhnout
2021-09-13 00:00:008-KStáhnout
2021-09-13 00:00:0010-QStáhnout
2021-08-05 01:00:008-KStáhnout
2021-08-05 00:00:008-KStáhnout
2021-08-02 01:00:008-KStáhnout
2021-08-02 00:00:008-KStáhnout
preloader